CyborD-DARA combination in first-line treatment for multiple myeloma Michael O’Dwyer, MD, PhD, from the National University of Ireland, Galway, Ireland, discusses the advantages of bringing daratumumab in the first-line setting as the CyborD-DARA combination ( cyclophosphamide, bortezomib and dexamethasone with daratumumab), for the treatment of multiple myeloma. Here, Prof. O’ Dwyer highlights that cyclophosphamide can […]

Read More

Multiple Myeloma: Stem Cell Transplant and Beyond 2021 Summary: Learn when patients with myeloma should consider transplant, steps involved in transplant, maintenance therapy options after transplant, and new therapies to manage multiple myeloma. Multiple myeloma is the most common cancer of the bone marrow. This presentation discusses transplant options and drug therapies for treating myeloma. […]

Read More

What Are The Stages Of Multiple Myeloma? Multiple myeloma is a cancer of plasma cells, which are a typically located in the bone marrow. The bone marrow is the soft, sponge-like tissue in the center of most bones. Dr. Cesar Rodriguez Valdes discusses what you need to know about multiple myeloma, including how it is […]

Read More

Screening programs for plasma cell disorders Irene Ghobrial, MD, of the Dana-Farber Cancer Institute, Boston, MA, and Maria-Victoria Mateos, MD, PhD, of the University of Salamanca, Salamanca, Spain, discuss the importance of screening and explain how a screening programme for early stages of myeloma could significantly improve survival outcomes for patients. Dr Ghobrial talks on […]

Read More

LESSON 4 – 4 Multiple Myeloma – MM

Read More